Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ENB vs GSK✓SelectedUSD · GSKENB vs GSK performance historyLatest closeAs of-0.50%11/20
Stock and ETF performance explorer

ENB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+88.3%
GSK return
+97.4%
Excess return
-9.1%
Maximum drawdown
-44.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.5%-0.1%-0.4%-0.5%
7D-4.2%-5.3%+1.2%-2.4%
30D-3.5%-3.7%+0.2%-2.4%
3M-9.1%-7.3%-1.9%-7.0%
6M-17.7%-4.2%-13.4%-17.0%
YTD+0.8%+0.9%-0.1%-1.2%
1Y-0.2%+7.3%-7.4%-4.5%
3Y+60.5%+52.7%+7.8%+28.0%
5Y+55.4%+40.1%+15.3%+26.0%
All+88.3%+97.4%-9.1%+26.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling